LAVA Therapeutics Cash Flow Statement 2020-2024 | LVTX

Fifteen years of historical annual cash flow statements for LAVA Therapeutics (LVTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$-41.70$-31.66$-42.20$-15.46
$-0.62$0.65$1.00$0.46
$6.17$0.94$1.71$0.96
$5.55$1.59$2.71$1.43
$1.87$-2.89$0.78$-1.07
$0$0$0$0
$0.33$1.41$1.62$0.32
$-5.03$35.59$8.44$5.48
$-2.83$34.11$10.84$4.73
$-38.97$4.04$-28.65$-9.31
$-0.73$-0.59$-0.76$-0.50
$0$0$0$0
$0$0$0$0
$0$0$0$0
$-16.91$9.93$-42.78$0
$-16.91$9.93$-42.78$0
$0$0$0$0
$-17.64$9.35$-43.55$-0.50
$0.47$0.61$0.68$2.03
$-1.04$-0.34$-0.34$-0.24
$-0.57$0.27$0.34$1.79
$0$0.02$94.19$0
$0$0.02$151$17.18
$0$0$0$0
$0$0$0$0
$-0.57$0.28$151$18.97
$-56.10$9.46$75.05$8.48
$5.04$4.11$3.91$0.56
$0$0$0$0